Delivery Order SPE2DB22D3301-SPE2DB24FZ4FD
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,124.88. The contract has an ultimate completion date of September 25, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ketorolac 60 mg/2 ml vial (2 ml). The contract, which does not have a set-aside designation, is a Delivery Order with a Firm Fixed Price of $1,164.06 and a completion date of June 16, 2025. The contract is funded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen Drug Corp is the prime contractor and there are no noted subcontractors. This contract is...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,357.72 firm fixed-price delivery order is for the supply of Ketorolac 30 mg/mL vials, a medication used for pain management. The contract has an ultimate completion date of February 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,424.50 firm fixed-price delivery order contract is for the supply of Ketorolac 30 mg/ml vials, a pain management medication. The contract has an ultimate completion date of April 15, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, worth $1,086.88, is for the delivery of Ketorolac 30 mg/ml vials, a pain management medication. The contract has a completion date of March 6, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $1,408.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ketorolac 15 mg/ml vial, a medication used for pain management. The contract has an ultimate completion date of June 10, 2024 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the delivery of Ketorolac 30 mg/ml vials. The award has a fixed-price delivery order contract type with a ceiling value of $2,287.60 and an ultimate completion date of May 31, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,909.40, is for the delivery of 4567643017 - Ketorolac 30 mg/ml vial, a pain management medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This contract, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, is for the delivery of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has a ceiling value of $2,437.24 and runs through September 9, 2024. It is a Firm Fixed Price Delivery Order contract type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor responsible for supplying this medication to the DLA, which supports military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. The delivery order, valued at $2,249.76, has a firm fixed price and an ultimate completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these injectable pain medication vials to support the DLA's medical supply needs. This award is not associated with a set-aside program. AmerisourceBergen holds several...